The COVID-19 Clinical Trials Alliance to is designed to help foster communication and sharing of information among sites and other stakeholders. According to Care Access Research, the healthcare industry urgently needs to increase the number of sites capable of running efficient, high-quality COVID-19 trials.
According to Ahmad Namvargolian, Care Access Research CEO and co-founder, time is of the essence in the global search for solutions to the pandemic.
“It is critical for study sponsors to find clinical trial sites fast enough to avoid delays in trials. Each day lost means lives lost," he said. "Now more than ever, the industry needs the ability to quickly connect research-capable clinics and hospitals with trial sponsors looking for them."
Namvargolian added the alliance provides site sponsors with a convenient way to connect with other sites to find partners to run COVID-19 trials.
The COVID-19 Clinical Trials Alliance aims to accelerate trials by matching research-enabled sites with study sponsors. The ideas is that by making hundreds of sites available in one place to COVID-19 studies, participants will be able to cut out the months of lag type typically encountered when looking for appropriate rsearch sites.
Additionally, Care Access Research announced it will provide support services to sites that want to run COVID-19 studies but lack necessary infrastructure.
Peder Pedersen, a Salt Lake City gastroenterologist and principal investigator currently readying COVID-19 studies, said such resources are invaluable for trials centered on the virus.
"While we focus primarily on GI studies at our site, we want to contribute to the COVID-19 response,” he said. “Care Access Research has made it possible for us to do that."
Sites, sponsors and CROs interested in participating or learning more about the alliance should visit the site at www.C19Alliance.com.